Songguo Zheng

 

Song Guo Zheng, M.D., Ph.D., Chair Professor of Shanghai Jiao Tong University School of Medicine

Dean, School of Cell & Gene Therapy

Principal Investigator, State Key Laboratory of Immunotherapy

EmailSong.Zheng@shsmu.edu.cn

 

Development and function of regulatory T cells, Immunology of Mesenchymal stem cells, Immunology of Autoimmune Diseases and tumor

 

Education

PhD of Immunology and Molecular Biology, French CNRS and University of Orleans

Master of Pathology and Immunology, Fudan University

B.S.Med, Anhui Medical University

 

Working experience

2023-Present, Chair Professor of Shanghai Jiao Tong University School of Medicine; Dean, School of Cell & Gene Therapy

2022-2023, Professor of Sun Yat-sen University

2018-2022, Ronald L. Whisler Chair in Rheumatology and Immunology, Professor of

Internal Medicine (tenure) and Director of Rheumatology and Immunology Research,

Division of Rheumatology and Immunology, Department of Internal Medicine

Ohio State University College of Medicine and Wexner Medical Center

2013-2018, Full Professor of Medicine (tenure) and Director, Rheumatology Research,

Division of Rheumatology, Department of Medicine, Penn State University Hershey College of Medicine

2009-2013, Associate Professor, Division of Rheumatology and Immunology,

Keck School of Medicine, University of Southern California, Los Angeles, CA

2004-2008, Assistant Professor, Division of Rheumatology and Immunology,

Keck School of Medicine, University of Southern California, Los Angeles, CA

2003-2004, Visiting Assistant Professor, Division of Rheumatology and Immunology,

Keck School of Medicine, University of Southern California, Los Angeles, CA

2000-2002, Postdoctoral Fellow, Division of Rheumatology and Immunology,

Keck School of Medicine, University of Southern California, Los Angeles, CA

1999-2000, Visiting Scientist, Pathology and Laboratory Medicine Department, School of Medicine, University of California, Los Angeles, CA,

1998-1999, Associate Professor, Director of Laboratory of Molecular Biology, Cancer Hospital,Shanghai Medical University

 

Achievements and Awards

Prof Zheng was the recipient of James Klinenberg Award, National Foundation Committee Overseas Cooperation Youth Fund Award, Freda Newton Memorial Award, Dona Foundation Immunologist Award, ACR Investigator Award, NIH STARA ward, Edmund Dubois Award and Distinguished Clinical Immunologist Award. Prof. Zheng was appointed as Editor-in-Chief of Am J Clin Exp Immunol, Associate Editor of J of Mol Cell Bio and Medcomm, Editorial Board Member of Cytokine & Growth Factor Reviews, Mol Cell Immunol, Frontiers Immunol, Theranostics, Molecular Therapy.

 

As a senior investigator, Prof. Zheng participated in the discipline evaluation of nine national foundations, including China, the United States, the United Kingdom, France, Canada, Australia, Poland, the Czech Republic, and South Africa, and led the project evaluation as the leader of the Rheumatoid, Skin and Oral diseases expert evaluation group of NIH in the United States. Prof. Zheng has been committed as the chairman and vice chairman of several international scientific societies and organizations. At present, more than 210 high-level papers have been published, and the papers have been widely cited at about 18,000 times. In addition, Prof. Zheng edited four English medical monographs.

 



Zheng Songguo

    Prof. Zheng is the expert the "Thousand Talents Program" of the Organization Department of the CPC Central Committee, and the Principal Investigator of National Key Research and Development Program of China. Prof. Zheng has been engaged in the pathogenesis and immunotherapy research of autoimmune and inflammatory diseases for decades, and has made series of international original achievements. Internationally, Prof. Zheng was the pioneer to discover TGF-β-induced regulatory T cells and one of the international pioneers in the field of dental mesenchymal stem cells. Up to now, several distinguished young scientists have been grown up under the assistance and guidance of Prof. Zheng. In the future, Prof. Zheng and his team will devote to the biological and clinical translational applications of immunomodulatory T cells and gingival mesenchymal stem cells, as well as the investigation of immuno-negative regulation intervention strategies in inflammatory diseases.